Large malignant ovarian tumors during pregnancy: Two cases

OncoTargets and Therapy

Volumn 7, Issue , 2014, Pages 2121-2125

  Xu, Dong ^a   Liang, Cheng ^a   He, Jing ^a  

^a Zhejiang University School of Medicine   (China)

Author keywords

Incidence; Ovarian malignancy; Pregnancy

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALPHA FETOPROTEIN; ASPARTATE AMINOTRANSFERASE; BLEOMYCIN; C REACTIVE PROTEIN; CA 125 ANTIGEN; CISPLATIN; D DIMER; ETOPOSIDE; GLYCYRRHIZIC ACID; HEMOGLOBIN; LABETALOL; LEUPRORELIN; MAGNESIUM SULFATE; PROTEIN; TUMOR ANTIGEN;

ABDOMINAL MASS; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ANTHROPOMETRIC PARAMETERS; APPENDECTOMY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; ASPIRATION; CANCER SURGERY; CASE REPORT; CESAREAN SECTION; CYSTADENOMA; CYTOPATHOLOGY; ECHOGRAPHY; FEMALE; FEMALE GENITAL TRACT PARAMETERS; FETUS MONITORING; GESTATIONAL AGE; GRANULOSA CELL TUMOR; HEMOGLOBIN BLOOD LEVEL; HISTOPATHOLOGY; HOSPITAL ADMISSION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERTENSION; IMMUNOHISTOCHEMISTRY; LAPAROTOMY; LEUKOCYTE COUNT; LYMPH NODE DISSECTION; NEUTROPHIL COUNT; OPERATIVE BLOOD LOSS; OVARIECTOMY; OVARY CANCER; OVARY CYST; PELVIC EXAMINATION; PELVIS TUMOR; PREGNANCY; PROTEIN BLOOD LEVEL; PROTEINURIA; SALPINGOOOPHORECTOMY; TREATMENT PLANNING; URINALYSIS;

EID: 84936990548     PISSN: 11786930     EISSN: 11786930     Source Type: Journal    
DOI: 10.2147/OTT.S69799     Document Type: Article

References (17)

1. Dobashi M, Isonishi S, Morikawa A, et al. Ovarian cancer complicated by pregnancy: analysis of 10 cases. Oncol Lett. 2012;3(3):577–580.
2. Kwon YS, Mok JE, Lim KT, et al. Ovarian cancer during pregnancy: clinical and pregnancy outcome. J Korean Med Sci. 2010;25(2): 230–234.
3. Gasim T, Al Dakhiel SA, Al Ghamdi AA, et al. Ovarian tumors associated with pregnancy: a 20-year experience in a teaching hospital. Arch Gynecol Obstet. 2010;282(5):529–533.
4. Machado F, Vegas C, Leon J, et al. Ovarian cancer during pregnancy: analysis of 15 cases. Gynecol Oncol. 2007;105(2):446–450.
5. Ueda M, Ueki M. Ovarian tumors associated with pregnancy. Int J Gynaecol Obstet. 1996;55(1):59–65.
6. Matsuyama T, Tsukamoto N, Matsukuma K, Kamura T, Kaku T, Saito T. Malignant ovarian tumors associated with pregnancy: report of six cases. Int J Gynaecol Obstet. 1989;28(1):61–66.
7. Halila H, Stenman UH, Seppala M. Ovarian cancer antigen CA 125 levels in pelvic inflammatory disease and pregnancy. Cancer. 1986;57(7):1327–1329.
8. Gezginc K, Karatayli R, Yazici F, Acar A, Celik C, Capar M. Ovarian cancer during pregnancy. Int J Gynaecol Obstet. 2011;115(2):140–143.
9. Tsai HJ. Metastatic bilateral malignant ovarian tumors associated with pregnancy. Taiwan J Obstet Gynecol. 2011;50(3):405–406.
10. Singhal SR, Nanda S, Chaudhry P, Sen J, Singhal SK. Metastatic bilateral malignant ovarian tumors associated with pregnancy. Taiwan J Obstet Gynecol. 2009;48(2):167–168.
11. Ngu S F, Cheung VY, Pun TC. Surgical management of adnexal masses in pregnancy. JSLS. 2014;18(1):71–75.
12. Marret H, Lhomme C, Lecuru F, et al. Guidelines for the management of ovarian cancer during pregnancy. Eur J Obstet Gynecol Reprod Biol. 2010;149(1):18–21.
13. Koo YJ, Kim TJ, Lee JE, et al. Risk of torsion and malignancy by adnexal mass size in pregnant women. Acta Obstet Gynecol Scand. 2011;90(4):358–361.
14. Moore RG, Miller MC, Eklund EE, Lu KH, Bast RC Jr, Lambert-Messerlian G. Serum levels of the ovarian cancer biomarker HE4 are decreased in pregnancy and increase with age. Am J Obstet Gynecol. 2012;206(4):349. e341–e347.
15. Whiteman DC, Siskind V, Purdie DM, Green AC. Timing of pregnancy and the risk of epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev. 2003;12(1):42–46.
16. Hasegawa T, Ishii Y, Yonezawa R, et al. Stage I ovarian cancer cases during early, mid and late pregnancy periods: three case reports and review of the literature. J Obstet Gynaecol Res. 2011;37(6):650–655.
17. Brewer M, Kueck A, Runowicz CD. Chemotherapy in pregnancy. ClinObstet Gynecol. 2011;54(4):602–618.